5987
CONCLUSION : Severe and sustained ocular hypertension may occur after intravitreal ranibizumab .
 adverse effect: sustained ocular hypertension, ranibizumab
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  sustained ocular hypertension, ranibizumab 
Answer:
 adverse effect: sustained ocular hypertension, ranibizumab